minnelide / Minneamrita Therap  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
minnelide / Minneamrita Therap
MinPAC, NCT03117920: A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer

Completed
2
19
US
Minnelide
Minneamrita Therapeutics LLC, Barts & The London NHS Trust, Translational Genomics Research Institute, Stand Up To Cancer, Cancer Research UK, Lustgarten Foundation, Queen Mary University of London
Pancreatic Cancer
07/19
07/19
NCT04896073: Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)

Recruiting
2
55
US
Minnelide
National Cancer Institute (NCI)
Adenosquamous Carcinoma of the Pancreas
09/26
09/26

Download Options